Skip to main content
SpringerLink
Log in

Why we are Treating Children with Growth Hormone: Lessons from the French Registry

  • Conference paper
Deciphering Growth

Part of the book series: Research and Perspectives in Endocrine Interactions ((RPEI))

  • 277 Accesses

Summary

Recombinant growth hormone has been used for approximately two decades and is now widely used worldwide in a variety of situations. Post-marketing data collected by growth hormone manufacturers have provided an enormous amount of information on the safety and efficacy of these treatments. In addition to this approach, national registries have provided data on a population basis. In France, the France-Hypophyse Association has collected data up to 1997 and has produced several analyses, which are summarized here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • August GP (1998) Symposium on controversies in the diagnosis of growth hormone deficiency. Pediatrics 102 (2 Pt 3): 517.

    Google Scholar 

  • August GP, Julius JR, Blethen SL (1998) Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience. Pediatrics 102 (2 Pt 3): 512–516.

    PubMed  CAS  Google Scholar 

  • Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A, (1997) Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 82: 418–420.

    Article  PubMed  CAS  Google Scholar 

  • Boman UW, Moller A, Albertsson-Wikland K (1998) Psychological aspects of Turner syndrome. J Psychosom Obstet Gynaecol 19: 1–18.

    Article  PubMed  CAS  Google Scholar 

  • Brook CGD (1997) Growth hormone: panacea or punishment for short stature? Brit Med J 315: 692–693.

    PubMed  CAS  Google Scholar 

  • Brook CGD, Kelnar CJH, Betts P (2000) Controversy: which children should receive growth hormone treatment. Arch Dis Child 83: 176–178.

    Article  PubMed  CAS  Google Scholar 

  • Cabrol S, Saab C, Gourmelen M, Raux-Demay MC, Le Bouc Y (1996) Syndrome de Turner: croissance staturopondérale et maturation osseuses spontanées. Arch Pediatr 3: 313–318.

    Article  PubMed  CAS  Google Scholar 

  • Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL (1998) Near normalisation of final height with adapted doses of growth hormone in Turner’s syndrome. J Clin Endocrinol Metab 83: 1462–1466.

    Article  PubMed  CAS  Google Scholar 

  • Carel JC, Tresca J-P, Letrait M, Le Bouc Y, Job J-C, Chaussain JL, Coste J (1997) Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab 82: 2117–2121.

    Article  PubMed  CAS  Google Scholar 

  • Carel JC, Ecosse E, Nicolino M, Tauber M, Leger J, Cabrol S, Bastié-Sigeac I, Chaussain JL, Coste J (2002) Adult height after long-term recombinant growth hormone treatment for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population-based registry. Brit Med J 325: 70–73.

    Article  PubMed  CAS  Google Scholar 

  • Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Leger J, Nicolino M, Brauner R, Chaussain JL, Coste J (2005) Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab 90: 1992–1997.

    Article  PubMed  CAS  Google Scholar 

  • Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J (2000) Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab 85: 2439–2445.

    Article  PubMed  CAS  Google Scholar 

  • Chu CE, Paterson WF, Kelnar CJ, Smail PJ, Greene SA, Donaldson MD (1997) Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner’s syndrome. Acta Paediatr 86: 160–164.

    Article  PubMed  CAS  Google Scholar 

  • Cole T (1993) Methodology for the analysis of longitudinal height data during puberty. KIGS Report 10: 37–44.

    Google Scholar 

  • Coste J, Letrait M, Carel JC, Tresca J-P, Chatelain P, Rochiccioli P, Chaussain JL, Job J-C (1997) Long term results of GH treatment in short stature children: a population register-based study. Brit Med J 315: 708–713.

    PubMed  CAS  Google Scholar 

  • Cutfield W, Lindberg A, Albertsson Wikland K, Chatelain P, Ranke MB, Wilton P (1999) Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatr Suppl 88: 72–75.

    Article  PubMed  CAS  Google Scholar 

  • Dacou-Voutetakis C, Karavanaki-Karanassiou K, Petrou V, Georgopoulos N, Maniati-Christidi M, Mavrou A (1998) The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment. Pediatrics 101: 663–668.

    Article  PubMed  CAS  Google Scholar 

  • Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner’s syndrome in adulthood. Endocr Rev 23: 120–140.

    Article  PubMed  CAS  Google Scholar 

  • Grumbach MM, Auchus RJ (1999) Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 84: 4677–4694.

    Article  PubMed  CAS  Google Scholar 

  • Guyda HJ (1999) Commentary. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84: 4307–4316.

    Article  PubMed  CAS  Google Scholar 

  • Guyda HJ (2000) Commentary. Growth hormone testing and the short child. Pediatr Res 48: 579–580.

    Article  PubMed  CAS  Google Scholar 

  • Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT (2004) Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 89: 193–199.

    Article  PubMed  CAS  Google Scholar 

  • Lagrou K, Xhrouet-Heinrichs D, Heinrichs C, Craen M, Chanoine JP, Malvaux P, Bourguignon JP (1998) Age-related perception of stature, acceptance of therapy, and psychosocial functioning in human growth hormone-treated girls with Turner’s syndrome. J Clin Endocrinol Metab 83: 1494–1501.

    Article  PubMed  CAS  Google Scholar 

  • Lyon AJ, Preece MA, Grant DB (1985) Growth curve for girls with Turner syndrome. Arch Dis Child 60: 932–935.

    PubMed  CAS  Google Scholar 

  • Marin G, Domene H, Barnes K, Blackwell B, Cassorla F, Cutler G. Jr. (1994) The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79: 537–541.

    Article  PubMed  CAS  Google Scholar 

  • Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, Francois I, Du Caju M, Maes M, De Schepper J (2003) Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 88: 4168–4174.

    Article  PubMed  CAS  Google Scholar 

  • Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G (1997) Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab 82: 1810–1813.

    Article  PubMed  CAS  Google Scholar 

  • Plotnick L, Attie KM, Blethen SL, Sy JP (1998) Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics 102 (2 Pt 3): 479–481.

    PubMed  CAS  Google Scholar 

  • Quigley CA, Crowe BJ, Anglin DG, Chipman JJ (2002) Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 87: 2033–2041.

    Article  PubMed  CAS  Google Scholar 

  • Ranke MB, Saenger P (2001) Turner’s syndrome. Lancet 358: 309–314.

    Article  PubMed  CAS  Google Scholar 

  • Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, m Sander S, Stahnke N, Steinkamp H, Said E, Sippell W (2002) Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 147: 625–633.

    Article  PubMed  CAS  Google Scholar 

  • Reiter EO, Blethen SL, Baptista J, Price L (2001) Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome. J Clin Endocrinol Metab 86: 1936–1941.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, Saenger P, Johanson AJ (1992) Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 121: 49–55.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger, P, Johanson AJ (1998) Growth hormone therapy of Turner’s syndrome: beneficial effect on adult height. J Pediatr 132: 319–324.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, LaFranchi S, Lippe BM, Loriaux DL, Melmed S, Preese MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GE (1995) Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80: 1532–1540.

    Article  PubMed  CAS  Google Scholar 

  • Ross JL, McCauley E, Roeltgen D, Long L, Kushner H, Feuillan P, Cutler GB, Jr. (1996) Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. J Clin Endocrinol Metab 81: 926–931.

    Article  PubMed  CAS  Google Scholar 

  • Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, Savage MO (1998) Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop, Pisa, Italy, 27–28 March 1998. Horm Res 50: 320–340.

    Article  PubMed  CAS  Google Scholar 

  • Sempé M, Hansson Bondallaz C, Limoni C (1996) Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1–22 years. Eur J Pediatr 155: 862–869.

    Article  PubMed  Google Scholar 

  • Siegel PT, Clopper R, Stabler B (1998) The psychological consequences of Turner syndrome and review of the National Cooperative Growth Study psychological substudy. Pediatrics 102 (2 Pt 3): 488–491.

    PubMed  CAS  Google Scholar 

  • Soriano-Guillen L, Coste J, Ecosse E, Leger J, Tauber M, Cabrol S, Nicolino M, Brauner R The StaTur study group, Chaussain JL, Carel JC (2005) Adult height and pubertal growth in Turner’s syndrome after treatment with recombinant growth hormone: observational follow-up study of the StaTur population-based cohort. J Clin Endocrinol Metab, in press.

    Google Scholar 

  • Stephure DK (2005) Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90: 3360–3366.

    Article  PubMed  CAS  Google Scholar 

  • Sybert VP, McCauley E (2004) Turner’s syndrome. New Engl J Med 351: 1227–1238.

    Article  PubMed  CAS  Google Scholar 

  • Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G (1996) Does growth-hormone supplementation affect adult height in Turner’s syndrome? Lancet 348: 25–27.

    Article  PubMed  CAS  Google Scholar 

  • The drug and therapeutic committee of the Lawson Wilkins pediatric endocrine society (1995) Guidelines for the use of growth hormone in children with short stature. J Pediatr 127: 857–867.

    Google Scholar 

  • Turner HH (1938) A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology 23: 566.

    Google Scholar 

  • van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88: 1119–1125.

    Article  PubMed  CAS  Google Scholar 

  • Vance ML, Mauras N (1999) Drug therapy: Growth hormone therapy in adults and children. New Engl J Med 341: 1206–1216.

    Article  PubMed  CAS  Google Scholar 

  • Chaussain JL, Carel JC (2005) Adult height and pubertal growth in Turner’s syndrome after treatment with recombinant growth hormone: observational follow-up study of the StaTur population-based cohort. J Clin Endocrinol Metab, in press.

    Google Scholar 

  • Stephure DK (2005) Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90: 3360–3366.

    Article  PubMed  CAS  Google Scholar 

  • Sybert VP, McCauley E (2004) Turner’s syndrome. New Engl J Med 351: 1227–1238.

    Article  PubMed  CAS  Google Scholar 

  • Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G (1996) Does growth-hormone supplementation affect adult height in Turner’s syndrome? Lancet 348: 25–27.

    Article  PubMed  CAS  Google Scholar 

  • The drug and therapeutic committee of the Lawson Wilkins pediatric endocrine society (1995) Guidelines for the use of growth hormone in children with short stature. J Pediatr 127: 857–867.

    Google Scholar 

  • Turner HH (1938) A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology 23: 566.

    Article  Google Scholar 

  • van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88: 1119–1125.

    Article  PubMed  CAS  Google Scholar 

  • Vance ML, Mauras N (1999) Drug therapy: Growth hormone therapy in adults and children. New Engl J Med 341: 1206–1216.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Endocrinology and INSERM U561, Groupe hospitalier Cochin-Saint Vincent de Paul and Faculté Cochin - Université Paris V, Paris, France

    Jean-Louis Chaussain

Authors
  1. Jean Claude Carel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Louis Chaussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Groupe Hospitalier Cochin-Saint Vincent de Paul-La-Roche Guyon, Hôpital Saint Vincent de Paul INSERM U.561 — Service d’Endocrinologie Pédiatrique, 74 à 82, Av Denfert Rochereau, 75674, Paris, France

    Jean-Claude Carel M.D.

  2. Inserm U584 Faculté de Médecine Necker Enfants Malades, 156, Rue de Vaugirard, 75730, Paris, France

    Paul A. Kelly Ph.D.

  3. Fondation IPSEN Pour la Recherche Thérapeutique, 24, rue Erlanger, 75781, Paris, France

    Yves Christen Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Carel, J.C., Chaussain, JL. (2005). Why we are Treating Children with Growth Hormone: Lessons from the French Registry. In: Carel, JC., Kelly, P.A., Christen, Y. (eds) Deciphering Growth. Research and Perspectives in Endocrine Interactions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28902-X_12

Download citation

Publish with us

Policies and ethics

Search

Navigation